ProCE Banner Activity

Navigating CAR T-Cell Therapy for Multiple Myeloma: Challenges, Patient Concerns, and Best Practices for Advanced Practice Providers

Clinical Thought

In this commentary, I highlight key challenges advanced practice providers face when caring for patients with multiple myeloma who undergo CAR T-cell therapy.

Released: February 10, 2025

Expiration: February 09, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC and Legend Biotech USA, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Legend Biotech USA Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Disclosure

Primary Author

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO: consultant/advisor/speaker: Bristol Myers Squibb, GlaxoSmithKline, Janssen, Sanofi.